Clik here to view.
Dr. Reddy’s Named by Science Magazine in Top 20 Global Pharma Employers List...
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) has been ranked among the top employers according to the 2024 Top Biotech and Pharma Employers Survey conducted by Science. This marks...
View ArticleClik here to view.
LabGenomics USA Completes Acquisition of IMD CLIA Labs
ROCKVILLE, Md. LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This acquisition...
View ArticleClik here to view.
ADx NeuroSciences与Alamar Biosciences宣布合作，提供v解决方案，加速生物制药临床开发
比利时根特与加州弗里蒙特 (美国商业资讯)– ADx NeuroSciences是Fujirebio的全资子公司，也是神经退行性疾病生物标志物开发的领先企业，而Alamar Biosciences则在超灵敏免疫分析技术领域处于领先地位。今天，双方宣布合作，利用Alamar的NULISA™（核酸链接免疫分析法）免疫分析平台和ARGO™...
View ArticleClik here to view.
Tempus Announces Collaboration With JW Pharmaceutical to Apply Real-World...
CHICAGO Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with JW Pharmaceutical, one of the most established pharmaceutical companies in Korea, to...
View ArticleClik here to view.
世界脳卒中機構、脳卒中ケアに関する施策を推進するためにグローバル連合を立ち上げ
ジュネーブ （ビジネスワイヤ） — 世界脳卒中デーである10月29日、世界脳卒中機構（WSO）は、現在、世界で死因の第2位、障害の原因の第3位となっている脳卒中に関する施策の推進を目的とした、グローバル連合の立ち上げを発表しました。...
View ArticleClik here to view.
世界卒中组织成立全球联盟以推动脑卒中护理政策行动
日内瓦 (美国商业资讯)– 在10月29日“世界卒中日”之际，世界卒中组织（WSO）宣布成立全球联盟，在当下卒中已成为全球第二大死因和第三大致残原因的背景下，加快针对卒中的政策行动。 在过去的三十年里，全球的卒中负担增加了一倍。 预计到2050年，卒中的影响将增加三分之一。 这一增长可能导致每年970万人死亡，与卒中相关的残疾患者人数也将大幅增加。...
View ArticleClik here to view.
ATLATL Hong Kong Innovation Center Officially Opens, Providing One-Stop...
HONG KONG ATLATL Hong Kong Innovation Center (ATLATL Hong Kong), a new state-of-the-art research facility designed to provide immediate, move-in-ready laboratory space for life science and biotech...
View ArticleClik here to view.
PopVax Announces 1.15 Million USD in Funding from the Bill ＆ Melinda Gates...
MUMBAI, India & HYDERABAD, India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using computational protein design, is pleased to announce...
View ArticleClik here to view.
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
SAN ANTONIO bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and other lung...
View ArticleClik here to view.
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated...
TOKYO & BASKING RIDGE, N.J. The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of datopotamab deruxtecan (Dato-DXd)-based...
View Article